Provided by Tiger Trade Technology Pte. Ltd.

Adverum Biotechnologies

4.36
0.0000
Volume:- -
Turnover:4.42M
Market Cap:96.26M
PE:-0.51
High:4.36
Open:4.36
Low:4.36
Close:4.36
52wk High:6.07
52wk Low:1.78
Shares:22.08M
Float Shares:11.36M
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):-8.5585
EPS(LYR):-6.6185
ROE:-417.79%
ROA:-76.90%
PB:-1.73
PE(LYR):-0.66

Loading ...

Mizuho Cuts Price Target on Adverum Biotechnologies to $5.50 From $12, Keeps Outperform Rating

MT Newswires Live
·
Oct 29, 2025

Adverum Biotechnologies price target lowered to $5.50 from $12 at Mizuho

TIPRANKS
·
Oct 29, 2025

Adverum Biotechnologies Is Maintained at Sector Perform by RBC Capital

Dow Jones
·
Oct 29, 2025

RBC Raises Price Target on Adverum Biotechnologies to $4 From $3, Keeps Sector Perform, Speculative Risk

MT Newswires Live
·
Oct 28, 2025

RBC Capital Keeps Their Hold Rating on Adverum Biotechnologies (ADVM)

TIPRANKS
·
Oct 28, 2025

Adverum Biotechnologies Inc : Truist Securities Cuts to Hold From Buy

THOMSON REUTERS
·
Oct 27, 2025

Truist Downgrades Adverum Biotechnologies to Hold From Buy, Reinstates Price Target at $5

MT Newswires Live
·
Oct 27, 2025

Adverum Biotechnologies (ADVM) was downgraded to a Hold Rating at Chardan Capital

TIPRANKS
·
Oct 25, 2025

Sector Update: Health Care Stocks Edge Higher Late Afternoon

MT Newswires Live
·
Oct 25, 2025

Adverum Biotechnologies downgraded to Hold from Buy at Truist

TIPRANKS
·
Oct 25, 2025

Eli Lilly (LLY.US) Announces Acquisition Bid for Gene Therapy Firm Adverum (ADVM.US)

Stock News
·
Oct 24, 2025

Eli Lilly Agrees to Acquire Adverum Biotechnologies

Dow Jones
·
Oct 24, 2025

Adverum Biotechnologies Shares Jump 16% Premarket After Eli Lilly to Acquire Co

THOMSON REUTERS
·
Oct 24, 2025

Adverum Biotechnologies trading resumes

TIPRANKS
·
Oct 24, 2025

Eli Lilly to Buy Adverum Biotechnologies for Up to $12.47 a Share

MT Newswires Live
·
Oct 24, 2025

Eli Lilly - Adverum Enters $65 Mln Promissory Note With Lilly for Ixo-Vec Trials

THOMSON REUTERS
·
Oct 24, 2025

Eli Lilly - to Buy Adverum Shares for $3.56 Plus CVR up to $8.91

THOMSON REUTERS
·
Oct 24, 2025

Positive Outlook for Adverum Biotechnologies: Buy Rating Based on Promising ixo-vec Therapy and Strategic Financing Plans

TIPRANKS
·
Sep 25, 2025

Adverum Biotechnologies (ADVM) Gets a Buy from Mizuho Securities

TIPRANKS
·
Sep 24, 2025

Adverum Biotechnologies Price Target Maintained With a $30.00/Share by HC Wainwright & Co.

Dow Jones
·
Sep 23, 2025